NaCT inhibitors (Evotec/Eternygen)

N/A

Report date: 2025/03/20 15:31:39
NME

Base Information

Drug NameNaCT inhibitors (Evotec/Eternygen)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNa(+)/citrate cotransporter inhibitors
TargetsNa(+)/citrate cotransporter
Therapy Area/IndicationsMetabolic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEvotec SE
China Registration ClassN/A

Develop Information

Active CompaniesEternygen GmbHEvotec SE
Inactive CompaniesN/A
Active IndicationsMetabolic Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A